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Abstract
Background: Endothelial cell junctions control blood vessel permeability. Altered permeability can be associated with
vascular fragility that leads to vessel weakness and haemorrhage formation. In vivo studies on the function of genes
involved in the maintenance of vascular integrity are essential to better understand the molecular basis of diseases linked to
permeability defects. Ve-ptp (Vascular Endothelial-Protein Tyrosine Phosphatase) is a transmembrane protein present at
endothelial adherens junctions (AJs).
Methodology/Principal Findings: We investigated the role of Ve-ptp in AJ maturation/stability and in the modulation of
endothelial permeability using zebrafish (Danio rerio). Whole-mount in situ hybridizations revealed zve-ptp expression
exclusively in the developing vascular system. Generation of altered zve-ptp transcripts, induced separately by two different
splicing morpholinos, resulted in permeability defects closely linked to vascular wall fragility. The ultrastructural analysis
revealed a statistically significant reduction of junction complexes and the presence of immature AJs in zve-ptp morphants
but not in control embryos.
Conclusions/Significance: Here we show the first in vivo evidence of a potentially critical role played by Ve-ptp in AJ
maturation, an important event for permeability modulation and for the development of a functional vascular system.
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Introduction
The vascular endothelium plays a physiological role as a
selective barrier between blood and extravascular tissues and it is
involved in the formation and in the maintenance of vascular
structures. The performing of these important functions is closely
related to the regulation of endothelial cell-cell adhesions [1,2].
Endothelial cells (ECs) contact each other by specialized
junctional regions which are comparable to Adherens Junctions
(AJs) and Tight Junctions (TJs) that are present in the epithelial
tissues. These junctions are formed by different transmembrane
adhesive proteins that bind, with their cytoplasmic domain, to
intracellular partners anchoring them to cytoskeletal filaments [3].
In AJs the adhesion is mediated, in part, by the transmembrane
protein VE-cadherin, which forms pericellular zipper-like struc-
tures along cell-cell contacts [3–6].
The failure of correct intercellular EC adhesion leads to a
reduced control of permeability and altered vascular morphogen-
esis. This may be the cause of important human pathologies which
include vascular malformations [7,8], stroke, edema or metastatic
spread of tumors [9].
The functionality and the integrity of cell-cell junctions are
affected by the phosphorylation level of adhesion proteins or of
their associated components. Many phosphatases and kinases are
directly or indirectly associated with AJs components and the
balance between the Protein Tyrosine Phosphatases (PTPs) and
kinases activity is critical for the regulation of junctional stability
[4,10,11]. A number of in vitro studies support a tight relationship
between the role of PTPs and the maintenance of EC-EC
junctional integrity and endothelial barrier function, showing that
high phosphorylation levels promote junctional disassembly and
the opening of a paracellular pathway [12–17].
Ve-ptp is a specific Vascular Endothelial-Protein Tyrosine
Phosphatase, which is exclusively expressed in endothelial cells
[18–20]. Mouse Ve-ptp encodes a 200 kDa polypeptide [21],
composed of 17 extracellular fibronectin type III-like repeats
(FN3), one transmembrane domain and one intracellular phos-
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phatase domain (PTP domain) [21]. Ve-ptp mutants and null-mice
die by E9.5 for severe angiogenic and vascular remodeling defects
[18,19].
The structure of the Ve-ptp extracellular domain suggests a role
of this protein as an adhesion receptor. In vitro studies have shown
that Ve-ptp and VE-cadherin interact through their extracellular
domains and this interaction modulates the VE-cadherin phos-
phorylation level affecting vascular permeability [21–25]. A recent
study has demonstrated in mouse that the dissociation of Ve-ptp
from VE-cadherin is a prerequisite for the destabilization of EC
contacts and for the opening of endothelial junctions [26].
Furthermore in vitro data have demonstrated a role of Ve-ptp in
fine-tuning the activity of two tyrosine kinases which play an
important role in vascular morphogenesis and in angiogenic/
remodeling processes such as Tie-2 and Vegfr2 [27,28].
In our work we could demonstrate the involvement of Ve-ptp in
the control of endothelium integrity and consequently its role in
the modulation of vascular permeability in vivo, using zebrafish as a
model system. In order to shed light on the structural role of Ve-
ptp in the EC junctions, we performed loss-of-function experi-
ments by injecting separately two independent splice-blocking
morpholinos that produced two altered forms of zve-ptp transcript.
This approach allowed us to assess the effects on vascular stability
of a zVe-ptp predicted altered protein lacking part of the
extracellular domain. Our data point to an involvement of Ve-
ptp in the maturation of AJs and to the important role played by
this protein in the vascular stability.
Results
Identification and sequence analysis of zve-ptp gene
We identified the zebrafish ve-ptp sequence (GenBank FJ435363)
using the combination of EST and genomic databases screening
and several 59 RACE steps. The putative zve-ptp cDNA sequence is
6.4 kb long. The 5.7 kb open reading frame encodes a protein of
1892 amino acids. The zVe-ptp protein sequence was scanned for
conserved protein domains. This analysis revealed that the
deduced zebrafish Ve-ptp protein sequence is composed of a
signal peptide, 15 fibronectin type III-like (FN3) repeats, a
transmembrane region and a unique PTP domain in the
intracellular region (Figure 1 A). Therefore, the structure of the
zve-ptp gene product is very similar to that of mouse Ve-ptp,
suggesting that Ve-ptp is a receptor-type protein with a tyrosine
phosphatase activity also in zebrafish. The comparison between
zVe-ptp protein and its human/rat and mouse orthologs revealed,
respectively, 44% and 45% amino acid identity, and 63% and
64% amino acid similarity (Figure 1 B).
zve-ptp is expressed in the developing vascular system
zve-ptp transcripts are both maternally and zygotically expressed
as deduced from our qualitative RT-PCR analysis (Figure 2 A).
Whole-mount in situ hybridization analysis revealed that zve-ptp is
specifically expressed in the developing vascular system of
zebrafish embryos and early larvae (Figure 2 B–K). At 26 hpf
(hours post fertilization), zve-ptp expression is predominantly visible
in the aortic vessels (Figure 2 B, C), as described at the earliest
stage analyzed in mouse (E9.5) [20]. In the head, zve-ptp is
expressed in the right and left lateral dorsal aortae (LDA, Figure 2
C) and the first mandibular arch (AA1; Figure 2 B). Histological
sections at the head level revealed also a periocular signal in the
cranial vasculature (Figure 2 D). The zve-ptp gene is expressed in
the whole dorsal aorta (DA) along trunk and tail region (Figure 2
B, B9). At this stage and at 2 dpf (days post fertilization), a strong
zve-ptp hybridization signal was detectable in the caudal region of
the axial vein (CV; Figure 2 B, B9, E). Starting from 2 dpf, zve-ptp
expression is observed mainly in vessels of small size such as in the
developing cranial vasculature, intersegmental vessels (Se) and at
3 dpf in the complete set of the aortic arches (Figure 2 F–J) and in
the dorsal longitudinal anastomotic vessels (DLAVs, Figure 2 K).
In conclusion, the expression pattern of zebrafish ve-ptp is closely
similar to that of mouse Ve-ptp [18–20].
The injection of zve-ptp morpholinos causes defects in
angiogenesis and in vascular integrity
To analyze the role of Ve-ptp during zebrafish early develop-
ment, we performed loss-of-function experiments injecting three
different morpholinos. The injection of different amounts of each
MO led to morphological defects and increased mortality in a dose
dependent manner (Figure S1). The first zve-ptp MO (MOa) is
designed to block mRNA translation. The injection of the selected
dose of 0.5 pmol/embryo of MOa in the tg(fli1:EGFP)y1 line [29]
led mainly to circulatory and angiogenic defects, without
substantially affecting embryo morphology at 2 dpf. The main
axial vessels appeared grossly normal in all injected embryos, even
if zve-ptp MOa morphants presented the reduction or the complete
absence of circulation (68%; n= 56). The main vascular defects
observed were in the intersomitic vessels of the tail (71%; n= 56),
which appeared truncated or with anomalous branching (Figure
S2 B). These data are in agreement with the Ve-ptp mutant and
null mice phenotypes, confirming in zebrafish the conservation of
Ve-ptp function in angiogenic and remodeling processes [18,19].
To shed light on the role played by Ve-ptp in ECs adhesion in
vivo, we decided to inject two different splice-blocking morpholi-
nos, zve-ptp MOb (MOb) and zve-ptp MOc (MOc), which
putatively target only the zVe-ptp extracellular domain without
directly impairing the intracellular catalytic domain. In fact, the
coding sequence of zve-ptp remains in frame downstream of the
MOs-induced RNA processing alterations. MOb injection resulted
in the production of an additional aberrant transcript encoding a
protein lacking the 11th FN3 repeat encoded by exon 12 (Figure
S2 E). MOb injection in the tg(fli1:EGFP)y1 line caused no evident
angiogenic/remodeling abnormalities at 2 dpf (Figure S2 C). At
this stage, embryos injected with the selected dose of 0.5 pmol
showed mainly circulatory and vascular defects (Figure S1 B). The
most evident defects in the axial vessels were detected at the level
of the CV plexus. About 50% (n= 113) of zve-ptp MOb morphants
presented blood cell accumulations in the CV region (Figure 3 C,
D). Histological sections revealed that these blood aggregates were
present within the blood vessels (Figure 3 D). In a large number of
zve-ptp MOb morphants, these cells exhibited only a slight pulsatile
motion in vivo and the circulation was not completely blocked
(movie S2), suggesting that there could be a loss of blood fluidity
due to fluid extravasation. In fact, embryos with the most severe
phenotype were characterized by the presence of a huge blood
stasis in the CV associated with the total loss of circulation
(Figure 3 E, F). A limited percentage of these morphants showed a
short tail and defects in the central nervous system (9%; Figure 3
E). In the vast majority of these zve-ptp morphants, the CV plexus
was severely disorganized and in some cases morphants showed
some blood elements out of the vein suggesting a leakage in the
vessel wall (Figure 3 F, F9). These defects, closely linked to the loss
of endothelial integrity, are supported by the presence of small
haemorrhages in the head region in 10% of zve-ptp MOb
morphants (Figure 3 I, J; Figure S1). The injection of the second
splice-blocking MO, zve-ptp MOc, gave qualitatively similar results
to MOb injection, though with a different penetrance (Figure S1
C). zve-ptp MOc targeted the intron 12/exon 13 boundary and its
injection resulted in the production of an additional aberrant
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transcript encoding a protein lacking the 12th FN3 repeat encoded
by exon 13 (Figure S2 F). At 2 dpf embryos injected with the
selected dose of 0.2 pmol of MOc in combination with 0.3 pmol of
p53 MO, to reduce non-specific defects in the central nervous
system, showed haemorrhagic phenotypes (21%; n= 53; Figure S1
C; Figure S3 C) and the presence of microstases in the CV plexus
(18%; n= 53; Figure S1 C; Figure S3 D). These results indicate
that permeability defects and vascular fragility are specifically
linked to the predicted impairment of the zVe-ptp extracellular
domain.
The impairment of zVe-ptp extracellular domain results
in increased vascular permeability associated with
endothelial AJ disorganization
The in vivo analysis of MOb and MOc morphant phenotypes
prompted us to directly investigate the effect of zve-ptp MOs
injection on endothelial permeability. We focused our attention on
the CV plexus, the region that showed the vast majority of the
vascular defects observed in zve-ptp morphants. Microangiography
experiments were performed injecting dextran-TMR (tetra-
methylrhodamine; molecular weight 70 kDa) at 2 dpf only on
morphants morphologically unaffected and with intact circulation.
These experiments showed that the main axial vessels were
lumenized and the circulation was substantially unaffected in all
injected embryos. The analysis was carried out at two different
time points after injection (t1 = 10 min; t2 = 15 min) when no
substantial dye extravasation was detectable in controls. Only 38%
of control embryos (n = 29) displayed dye extravasation in the tail
region indicative of the presumably physiological outflow. On the
contrary, about 80% of the analyzed zve-ptp MOb morphants
(n = 32) showed a leakage of the dye out of the CV and the DLAVs
(Figure 4 D, D9, D0, F, F9, F0), pointing out the crucial role played
by zVe-ptp in the modulation of vascular permeability. We
performed the same analysis on zve-ptp MOc and MOa injected
embryos. We obtained qualitatively similar results in embryos
injected with MOc (61% of dye extravasation; n = 20; Figure S4).
Unfortunately, a relevant number of MOa morphants displayed
severe circulatory defects preventing us from performing micro-
angiography on these embryos. MOa morphants with intact
circulation did not display a significant increase in the percentage
of dye leakage (17%; n= 18; Figure S4 G) with respect to control
embryos (11%; n= 9; Figure S4 G).
Figure 1. The zVe-ptp protein. (A) Schematic representation of the zVe-ptp domain structure. The protein is composed of an intracellular domain
(red), a transmembrane region (green) and 15 fibronectin type III-like repeats (light blue). The amino acid residue (aa) numbers of each domain are
indicated. SP: signal peptide; FN3: fibronectin type III-like repeat; PTP: tyrosine phosphatase domain. (B) Table of amino acid identity (and similarity)
between zVe-ptp protein and its human, rat and mouse orthologs. The table is the result of multiple alignment of proteins using the VECTOR NTI
version 10.0 (Invitrogen) program and the following sequences: Homo sapiens (gi: 75517206); Mus musculus (gi: 23618914); Rattus norvegicus (gi:
109480532).
doi:10.1371/journal.pone.0051245.g001
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To gain insight into the vascular ultrastructure of zve-ptp
morphants, we decided to use a transmission electron microscopy
(TEM) approach. We focused our attention on tail vessel ECs of
zve-ptp morphants and std-MO injected embryos at 2 dpf
(Figure 5). Normal blood vessels are formed by flat endothelial
cells that contact each other by numerous and extensive junctional
complexes, which appear as well-organized structures (Figure 5
A9). In all zve-ptp morphants, we primarily detected a statistically
significant reduction of the number of junctions (Figure 5; Figure
S5 C). Most of the observed junctional complexes appeared as
disorganized electron-dense areas (data not shown). Noteworthy
mainly MOb and MOc morphant ECs are characterized by
digitiform extensions at endothelial cell contacts (Figure 5 C9, C0,
D; Figure S5 B). These protrusions of the EC membrane, referred
to as filopodia in literature, are transitional structures that normally
characterize AJs before the establishment of the definitive adhesive
complex and retract after the maturation of the junction [30–32].
Our analysis highlights that controls are totally devoid of these
digitiform EC-EC contacts at this developmental stage. Moreover,
zve-ptp morphants presented a three-fold decrease in the percent-
age of EC-EC borders showing well-organized junctional com-
plexes, which is highly significant (p,0.001), with respect to
controls (Figure 5 D; Figure S5).
We also performed immunofluorescence experiments in order
to investigate the expression levels and the distribution of VE-
cadherin and ZO-1, a tight junction marker. As Blum and
colleagues described, these two proteins are localized at EC-EC
borders [33]. Whole-mount immunofluorescence experiments
showed that the expression of ZO-1 and VE-cadherin in zve-ptp
MOb morphants and control embryos at 2 dpf is comparable.
This indicates that the expression of two important junctional
proteins in adherens and tight junctions is not affected by zve-ptp
MOb injection, though their overall distribution along the cell
borders appeared different with respect to controls probably due to
an altered EC shape (Figure 6). In order to understand whether
knockdown of VE-PTP could alter endothelial cell-cell junction
organization, we studied human umbilical vein endothelial cells
(HUVECs) upon treatment with VE-PTP siRNA. As reported in
Figure S6, we found that the distribution of different proteins
involved in adherens junction (VE-cadherin, p120) and tight
junction organization (ZO-1, claudin 5) was not affected by
silencing of VE-PTP. We even detected a slight increase in
expression of some of these proteins after VE-PTP knockdown as
shown in Western blot assays (Figure S6 B).
VE-cadherin phosphorylation in Y658 was strongly increased in
absence of VE-PTP (Figure S6 A). Phosphorylation of this tyrosine
has been related to increase in VE-cadherin internalization and
turn over.
These data highlight a potential novel role of zVe-ptp in the
maturation of EC junctions, corroborating the importance of this
protein in junction complex stability and integrity.
Discussion
Endothelial junction integrity is essential for the maintenance of
the physiological role of the endothelium. Vascular permeability is
strongly modulated by transmembrane proteins that control
Figure 2. Spatio-temporal expression pattern of zve-ptp. (A) zve-ptp and b-actin temporal expression analysis is performed by qualitative RT-
PCR analysis on total RNAs extracted from oocytes and different embryonic and larval stages (from 2 cells to 120 hpf). Negative control is showed in
the right-most line. The sizes of the obtained PCR fragments are indicated. zve-ptp is expressed both maternally and zygotically during zebrafish
development. (B–K) The zve-ptp spatial expression was analyzed by WISH at various developmental stages. Lateral (B) and dorsal (C) view of a 26 hpf
embryo with anterior to the left; (B9) higher magnification of the tail shows the expression in the DA and CV. The transverse sections at the level of
the head (D) and the tail (E) of a 26 hpf embryo labelled with zve-ptp probe show in detail the signal in head vessels and in the DA and CV. Lateral
views of head (F) and magnification of the tail (G) of a 2 dpf embryo and lateral view of the head of a 3 dpf embryo (H). Cross sections at the level of
head (I), aortic arches (J) and trunk (K) of a 3 dpf embryo. Black asterisk: AA1; black arrowhead: DA; white arrowhead: CV; red arrowhead: LDA; white
arrows: vessels around the eyes; blue arrows: cranial vessels; black arrow: Se; red asterisks: aortic arches; light blue arrows: vessels around the lens;
white asterisks: DLAVs.
doi:10.1371/journal.pone.0051245.g002
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interendothelial adhesions. Ve-ptp is the first known tyrosine
phosphatase adhesion protein that is only expressed in endothelial
cells [18–20]. The analysis of mutant and null-mice phenotypes
suggested that Ve-ptp is essential for angiogenic processes and
vascular system remodeling [18,19]. Furthermore a recent paper
showed in mouse the importance of Ve-ptp/VE-cadherin associ-
ation in the stabilization of endothelial cell contacts [26], but no
thorough investigation has been published so far on the structural
role played by this protein in endothelial cell junctions’ maturation
in vivo. We decided to characterize the role of Ve-ptp in the
developing vascular system in zebrafish. The structure of the zve-
ptp gene product is very similar to mouse Ve-ptp, suggesting that
Ve-ptp is a receptor-type protein with a tyrosine phosphatase
activity also in zebrafish. zve-ptp showed a selective expression in
the endothelium during embryonic development, such as de-
scribed in mouse. The injection of the first tested morpholino
(MOa), which blocks Ve-ptp translation, suggested an evolutionary
conserved role of Ve-ptp in angiogenic/remodeling processes.
The injection of two different splice-blocking MOs (MOb and
MOc), designed on two different intron/exon junctions, produced
altered forms of zve-ptp transcript. We suppose that the obtained
gene products lack only part of the extracellular domain,
responsible for the interaction with VE-cadherin [21], without
putatively altering the catalytic domain. RT-PCR performed to
test the efficacy of splice-blocking MOb showed that only a
fraction of the zve-ptp mRNA is incorrectly spliced due to the steric
action of the splice-blocking MO. We speculate that the minor
aberrant transcript might give rise to an aberrant protein that
could be incorporated in plasma membrane, although we cannot
formally prove it due to a lack of specific antibodies against the
zebrafish Ve-ptp protein. To demonstrate the specificity of
phenotypes obtained by the MOb injection, we designed a second
splice-blocking MO (MOc) targeting the extracellular domain.
Phenotypes were qualitatively comparable indicating that failings
in junctions’ maturation and permeability defects are linked to the
impairment of the extracellular domain rather than the total zVe-
ptp knockdown.
zve-ptp MOb and MOc morphants displayed a phenotype which
is only partially overlapping with the translation-blocking MO
(MOa) as shown in Figure S1 and S2. Splice-morphants presented
defects related to a loss of endothelium integrity without gross
angiogenic defects, suggesting that even a partial modification of
zve-ptp gene product may interfere with the maintenance of an
intact endothelium. Half of zve-ptp MOb morphants presented
blood cell accumulations into the CV plexus that could be due to
the extravasation of blood fluid out of the vein. However, only the
zve-ptp MOb morphants that are characterized by the most severe
phenotype presented blood elements outside of the vein, indicative
of a severe impairment of endothelial cell-cell integrity.
The lack of an overt cell integrity phenotype in most zve-ptp
splice-morphants prompted us to analyze vascular permeability.
The injection into zebrafish blood flow of a fluorescent dye
confirmed in vivo an increased vascular permeability. By microan-
giography experiments we detected an increased extravasation of
the dye out of the CV plexus and the DLAVs in zve-ptp MOb and
MOc morphants with respect to controls (80% vs 38% extrava-
sation in MOb injected embryos and 61% vs 37% in MOc
injected embryos, respectively). We performed microangiography
experiments only in morphants that showed blood circulation. The
vast majority of MOa injected embryos displayed circulatory
defects and so they have not been included in this analysis.
Moreover zve-ptp MOa morphants in vivo did not show phenotypes
referable to an altered vascular permeability (such as head
haemorrhages and/or vessel blood stases). Consequently, we did
not notice a significant percentage of MOa morphants with dye
extravasation within the few circulating embryos that could be
analysed by microangiography.
Leaks in the vessel wall could be related to a reduction or
instability of cell-cell adhesion at the level of the AJs. We suppose
that, in our zve-ptp MOb and MOc morphants, if the aberrant
zVe-ptp protein lacking part of the extracellular region is
incorporated in the plasma membrane, its interaction with VE-
cadherin might be disturbed. This hypothesis is supported by the
association demonstrated in vitro, at the level of the extracellular
domains, between Ve-ptp and VE-cadherin, which is accompa-
nied by the enhancement of the adhesive function of the latter, as
Nawroth and colleagues showed in transfected cells [21]. These
studies have demonstrated that the conformation or the clustering
of VE-cadherin, affected by the physical interaction with Ve-ptp,
influence its adhesive activity and consequently cell layer
permeability [21]. Furthermore, other in vitro evidences showed
that the adhesive function of VE-cadherin is strongly reduced by
Figure 3. The zve-ptp MOb injection caused blood cell
aggregates in the CV and head haemorrhages at 2 dpf. (A)
Bright-field image and (B) cross section of the tail of a control embryo
injected with std-MO. (C) Bright-field image and (D) cross section of the
tail of an embryo injected with MOb showing blood aggregates in CV
(red arrow). (E) Lateral view and (F) cross section at the level of the CV of
a MOb injected embryo with a severe phenotype; (F9) higher
magnification of the boxed area in F showing some blood elements
out of the CV. (G) Bright-field image and (H) cross section of the head of
a std-MO injected embryo. (I) Bright-field image and (J) cross section of
the head of an embryo injected with MOb showing small haemorrhages
(black arrowhead). (J9) Higher magnification of the boxed area in J
showing blood accumulation in the tissues around the eye of zve-ptp
morphant. Anterior to the left. DA: dorsal aorta; CV: caudal vein; red
arrow: blood aggregates; black arrowhead: haemorrhage.
doi:10.1371/journal.pone.0051245.g003
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the silencing of Ve-ptp expression in ECs [22]. A recent paper
showed in vivo the effects on vascular integrity and permeability of
the zebrafish VE-cadherin knockdown [34]. zVE-cadherin mor-
phants presented head haemorrhages and permeability defects
similar to the phenotypes we observed in our zve-ptp MOb and
MOc morphants.
The ultrastructural analyses revealed a drastic reduction and
disorganization of junctions in all zve-ptp morphants ECs (MOa,
MOb and MOc injected embryos). The most striking feature of
ECs in zve-ptp morphants at 2 dpf, in contrast to controls ECs at
the same stage, is the presence of digitiform protrusions at EC-EC
contacts. These plasma-membrane extensions are normally
transitional structures essential to initiate a cell-cell contact. When
cadherins establish mature AJs, the protrusions retract, and the
cell-cell contact appears as a closed zipper [30–32]. Immunoflu-
orescence experiments showed that VE-cadherin and ZO-1 were
present in EC borders of zve-ptp morphants. In order to get some
mechanistic insights into the vascular alterations observed in zve-
ptp morphants, we switched to an endothelial cell culture system.
Immunofluorescence staining of different markers showed that in
HUVEC the silencing of VE-PTP expression did not alter
adherens or tight junction architecture. However, VE-cadherin
phosphorylation, an effect that was linked to dissociation of p120,
was significantly increased. Although we could not observe a
significant redistribution of p120 from cell-cell junctions, VE-
cadherin phosphorylation may be related to the vascular fragility
observed in vivo in the present paper. Tyr-658 plays a critical role
in the regulation of VE-cadherin function, in fact phosphorylation
at this site led to the inhibition of cell-cell barrier function [35].
Therefore, we speculate that endothelial AJs in our zve-ptp
morphants present an immature structure in which VE-cadherins
could be unable to contact each other in order to form the correct
and mature adhesion complex. This is an exciting hypothesis that
remains to be further investigated. With this aim, since high
phosphorylation levels promote the junctional disassembly and the
opening of a paracellular pathway [12–17], it could be interesting
to evaluate the expression level of phospho VE-cadherin also in
our zve-ptp morphants. Unfortunately, at present, a specific anti-
phospho VE-cadherin antibody that works in zebrafish is not
available.
In conclusion, zebrafish Ve-ptp is a specific vascular endothelial
PTP. The phenotypes observed in zve-ptp morphants, supported by
microangiographies and ultrastructural analysis, suggest a reduc-
tion in AJs stability that is reflected in integrity and permeability
defects. Our data suggest that Ve-ptp could play a novel critical
role in junctional complex maturation, an important event for




Current Italian national rules: no approval needs to be given for
research on zebrafish embryos. Fish were maintained/raised
according to EU regulations on laboratory animals (Directive
2010/63/EU).
Zebrafish lines and maintenance
Zebrafish (Danio rerio) embryos obtained from natural spawning
were raised and maintained according to established techniques
[36]. Embryos were staged according to morphological criteria
[37]. Beginning from 24 hpf, embryos were cultured in fish water
Figure 4. The zve-ptp MOb injection caused an increase in vascular permeability. (A–D) Microangiographies were performed on
tg(fli1:EGFP)y1 embryos at 2 dpf by the injection of dextran-TMR (tetramethylrhodamine; molecular weight 70 kDa). All microinjected embryos
presented blood circulation. Confocal images of tail vessels of std-MO (A, C) and MOb injected embryos (B, D) at t1 = 10 minutes (A, B) and
t2 = 15 minutes (C, D). (E, F) Merge of the images at t2 of embryos injected with std-MO and MOb with the respective images of the tail vessels
obtained using tg(fli1:EGFP)y1 line. (A9–F9; A0–F0) Higher magnifications of the respective boxed areas. Asterisks: dye extravasation.
doi:10.1371/journal.pone.0051245.g004
Ve-ptp Modulates Adherens Junction Maturation
PLOS ONE | www.plosone.org 6 December 2012 | Volume 7 | Issue 12 | e51245
containing 0.003% PTU (1-phenyl-2-thiourea; SIGMA) to prevent
pigmentation and 0.01% methylene blue to prevent fungal growth.
The following lines were used: AB (obtained from the Wilson
lab, University College London, London, United Kingdom) and
tg(fli1:EGFP)y1 [29] (from the Lawson lab, University of Massa-
chusetts Medical School, Boston, USA).
zve-ptp identification
We screened a zebrafish EST (Expressed Sequence Tag)
database (http://image.llnl.gov/using) using the mouse Ve-ptp
nucleotide sequence (gi: 23618913) as a query. We identified an
EST (clone IMAGE 4728598) associated with a 3,4 kb cDNA
cloned into the pBK-CMV vector, that contains the 39 UTR and
Figure 5. Ultrastructural defects in endothelial cells of zve-ptpmorphants at 2 dpf. (A–C) Electron microscopy at the level of the CV plexus
of a std-MO (A) and a MOb injected embryo (B, C). (A9–C9, C0) Higher magnifications of the respective boxed areas. (A9) Numerous and extensive
junctional complexes are visible in a control embryo. (B9) No junctional complexes are detectable between two ECs in a morphant. All analyzed
embryos presented blood circulation. Arrowheads: junctional complexes; asterisks: digitiform EC-EC contact; CV: caudal vein; er: erythrocytes; DA:
dorsal aorta; EC: endothelial cell. (D) Quantitative analysis of % EC-EC borders with any type of junctions (adherens and/or tight junctions), without
junctions and without junctions but with digitiform EC-EC contacts in controls and in zve-ptp morphants. The graph shows the analysis performed on
the acquired images of trunk and tail regions of MOb and MOc injected embryos. We analyzed 112, 150 and 280 EC-EC borders out of three std-MO,
seven zve-ptp MOb and five zve-ptp MOc independent injected embryos respectively.
doi:10.1371/journal.pone.0051245.g005
Ve-ptp Modulates Adherens Junction Maturation
PLOS ONE | www.plosone.org 7 December 2012 | Volume 7 | Issue 12 | e51245
Figure 6. Immunofluorescence analysis by confocal microscopy of endothelial intercellular junctions. Immunofluorescence
experiments were performed on tg(fli1:EGFP)y1 embryos at 2 dpf. Confocal images of tail vessels of std-MO (A, E) and MOb injected embryos (B,
F) labeled with an anti-ZO-1 and VE-cadherin antibody (red) and the respective merged images (C, D, G, H). Se: intersegmental vessels.
doi:10.1371/journal.pone.0051245.g006
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part of the coding sequence, encoding the catalytic domain (PTP
domain), the transmembrane region and the last 6 fibronectin type
III-like repeats (FN3).
We then used the partial cDNA sequence to screen the zebrafish
genomic database (www.ensembl.org) and by several 59 RACE
steps on total RNA extracted from 26 hpf stage embryos, we
assembled the entire zebrafish ve-ptp (zve-ptp) cDNA sequence
(GenBank FJ435363).
59 RACE was carried out using 59 RACE System for Rapid




embl-heidelberg.de/) server’s tools and VECTOR NTI version
10.0 (Invitrogen) program were used for basic handling and
analyses of nucleotide sequence and protein data. Additional
information can be made available on request.
Expression pattern analysis
RT-PCR (Reverse Transcription-Polymerase Chain Reaction)
was performed on total RNAs prepared from zebrafish oocytes
and embryos at different developmental stages using the Totally
RNA Isolation Kit (Ambion) or the RNAgents Total RNA
Isolation System (Promega, Madison, WI, USA), treated with
DNase I RNase free (Roche, Basel, Switzerland) to avoid possible
contamination from genomic DNA and then reverse transcribed
using the ImProm-II Reverse Transcription System (Promega) and
Random primers according to manufacturers’ instructions.
The cDNAs were then subjected to PCR amplification using
GOTaq polymerase (Promega) following the manufacturer’s
instructions.
The following primers were used for PCR reactions:
4F: 59 GTGGCCCAGACTTTCTGAAC 39
5R: 59 TGTGCGGCCGTATATAGAGA 39
Specific b-actin primers [38] were used to check cDNA quality
and possible genomic contamination.
Whole-mount in situ hybridization (WISH) was performed
substantially as described [39].
For zve-ptp probe preparation, a 1300 bp template (spanning the
7th–11th FN3 encoding region) was generated by RT-PCR on total
RNA extracted from 26 hpf embryos using the following primers:
4F: 59 GTGGCCCAGACTTTCTGAAC 39
6R: 59 GTTTGTCCCTCTGCAACGAC 39
PCR products were cloned into the pCRII-TOPO vector
(Invitrogen).
The cDNA-containing plasmid was linearized with BamHI
enzyme and transcribed with T7 RNA polymerase (Roche) for
antisense riboprobe synthesis or linearized with XhoI and
transcribed with Sp6 RNA polymerase (Roche) to synthesize the
sense probe.
Images of stained embryos were taken with a Leica MZFLIII
epifluorescence stereomicroscope equipped with a DFC 480 digital
camera and IM50 Leica imaging software (Leica, Germany).
For histological sections, stained embryos were re-fixed in 4%
PFA, dehydrated, wax embedded, sectioned (8 mm) by a
microtome (Leitz 1516) and stained with eosin. Images were
taken with an Olympus BH2 microscope (Tokyo, Japan), equipped
with a Leica DFC 320 digital camera and the IM50 software
(Leica, Germany).
Morpholino injections and detection of splice variants of
zve-ptp transcript by RT-PCR
Three different antisense morpholinos (MOs), MOa (zve-ptp
MOa; 59 TACATTCCGTTGCGTCCACCACCAT 39), MOb
(zve-ptp MOb; 59 AGGGCTCTGAAACACACACAAACAC 39)
and MOc (zve-ptp MOc; 59GACCTGGAGATGTGGAAA-
CAAAACA 39), were synthesized by Gene Tools (Philomath,
OR, USA).
MOa was designed on the region surrounding the putative
second AUG translation start codon of the transcript lying in a
good Kozak consensus context; on the contrary, the first in frame
AUG lies in a poor Kozak context, lacking a G at position +4 [40].
MOb and MOc are two splice-blocking MOs designed on the
intron 11/exon 12 boundary and intron 12/exon 13 boundary,
respectively.
As a control for unspecific effects, each experiment was
performed in parallel with a std-MO (standard control oligo) with
no target in zebrafish embryos.
MOc was injected in combination with p53 MO (59
GCGCCATTGCTTTGCAAGAATTG 39).
All morpholinos were diluted in Danieau solution [41] and
injected at 1–2 cells stage. Rhodamine dextran (Molecular Probes)
was usually co-injected as a tracer. After injection, embryos were
raised in fish water at 28uC and observed up to the stage of
interest. For a better observation, the injected embryos were
anaesthetized using 0.016% tricaine (Ethyl 3-aminobenzoate
methanesulfonate salt, SIGMA) in fish water. Images were
acquired and larvae were video-taped by using a Leica MZ FLIII
microscope equipped with a Leica DFC 480 digital camera and
the IM50 software (Leica, Germany).
At 2 dpf, total RNA was extracted from embryos injected with
MOb, MOc and std-MO and from uninjected embryos with
RNAgents Total RNA Isolation System (Promega). Reverse
transcription was carried out with the ImProm-II Reverse
Transcription System (Promega) and random primers according
to manufacturers’ instructions.
PCR was performed to detect splice variants of zve-ptp.
The following primers were used:
MObFOR2: 59 TGGTCCTCTGCTGATGGAGA 39
MObREV2: 59 CCCCAGGGTCGTGTGATAGT 39
MOcFORB: 59 GGCGGATAATGAGCTTAGCA 39
MOcREVB: 59 CTCCACGTCTGCACTGTAGC 39
RT-PCR products were sequenced.
Microangiography
Microangiography of zebrafish embryos was performed essen-
tially as previously described [42]. tg(fli1:EGFP)y1 embryos were
injected with Dextran-TMR (tetramethylrhodamine; molecular
weight 70 kDa, Molecular Probes). Dextran-TMR was dissolved
in PBS at 25 mg/ml and microinjected into the sinus venosus of
anesthetized zebrafish embryos at 2 dpf.
Specimens were scanned using a Leica TCS NT confocal
microscope. For each sample, two images of the fluorescent tracer
dye were collected, 10 min (t1) and 15 min (t2) after dye injection.
Pictures of the fluorescent vascular tree were also taken. The
collected data were processed by ImageJ 1.41o: the pictures
obtained at t1 were subtracted to the images obtained at t2, to
evaluate changes of fluorescence occurred within 5 min for each
injected embryo.
Histological sections and electron microscopy
2 dpf zebrafish embryos were manually dechorionated and
fixed overnight at 4uC with 1.5% glutaraldehyde and 4%
paraformaldehyde in 0.1 M sodium cacodylate buffer pH 7.3.
They were rinsed in the same buffer and post-fixed for 1 hour in
sodium-cacodylate-buffered 1% osmium tetroxide. The samples
were then dehydrated in a graded ethanol series, transitioned to
propylene oxide and embedded in Epon 812-Araldite. Sections
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were obtained using a Reichert UltracutE instrument. 0.7–0.8 mm
sections were stained with gentian violet and basic fuchsin and
photographed with Olympus BH2 microscope (Tokyo, Japan),
equipped with a Leica DFC 320 digital camera. Thin sections
were cut at 60–70 nm and placed onto copper grids, stained with
2% alcoholic uranyl acetate and aqueous lead citrate and analyzed
under a Jeol 100 SX electron microscope.
Cell culture and Small Interfering RNA (siRNA)
experiments
Human umbilical vein endothelial cells (HUVECs) were
cultured in MCDB131 medium (Invitrogen) containing 20%
FCS, glutamine (2 mM), sodium pyruvate (1 mM), heparin
(100 mg/ml, from porcine intestinal mucosa; Sigma), and endo-
thelial cell growth supplement (ECGS) (5 mg/ml, made from calf
brain). HUVECs between passage 3 and 5 were used for the
experiments. HUVECs were starved in MCDB131 medium
(Invitrogen) containing 1% BSA for 3 hrs before proceeding with
the experiments. Knockdown of human VE-PTP was established
by 48-hrs transfection of cells with the ON-TARGET plus
SMART pool siRNAs from Dharmacon and the corresponding
non-Targeting siRNAs control. Transfection was performed with
LipofectAMINE 2000 (Invitrogen) in accordance with the
manufacturer’s instructions.
Immunofluorescence experiments
Embryos at 2 dpf were fixed in 4% PFA 2 hours at room
temperature and the immunofluorescence was performed as
previously described [33] using mouse anti-human ZO-1, 1:200
(Zymed) and Alexa fluor 555 goat anti-mouse, 1:500 (Molecular
Probes) and rabbit anti-zebrafish VE-cadherin (CDH-5; from M.
Affolter) 1:500 and Alexa fluor 555 goat anti-rabbit, 1:500
(Molecular Probes). Images of the tail were taken with a Leica
TCS NT confocal microscope equipped with an argon laser.
Cells were fixed and permeabilized with 3% paraformaldehyde,
0.5% Triton X100 (Tx) in PBS for 3 min followed by further
15 min fixation with 3% PFA in PBS (VE-cadherin, PY658 VE-
cadherin, p120) or with ice-cold methanol for 5 min (ZO-1 and
Claudin5). For immunostaining primary and secondary antibodies
were diluted in PBS-5% BSA. Confocal microscopy was
performed with a Leica TCS SP2 confocal microscope. For
comparison purposes, different sample images of the same antigen
were acquired under constant acquisition settings. The following
antibodies were used: goat anti-VEC (Santa Cruz), mouse anti-
p120 (BD Transduction Laboratories), rabbit anti-ZO-1 (Invitro-
gen), mouse anti-Claudin5 (Invitrogen), mouse anti-Vinculin
(Sigma). Affinity purified rabbit antibody to VE-PTP and to
pY658-VE-cadherin were produced and purified by New England
Peptide.
Western blotting
Western blotting has been performed using standard protocols.
Protein concentrations were determined using a BCA Protein
Assay Kit (Pierce) according to manufacturer’s instructions.
Statistical analysis
Statistical analysis was performed with one-way analysis of
variance technique and with Dunnett’s post test using GraphPad
PRISM version 5.0 (GraphPad, San Diego, California). A p value
,0.05 indicates a statistically significant effect.
Supporting Information
Figure S1 Vascular and circulatory phenotypes associ-
ated to the injection of different amounts of zve-ptp
MOa, zve-ptp MOb and zve-ptp MOc. (A–C) Histograms
show the quantification of survival (left panel) and phenotypic
classes (right panel) at 2 dpf of tg(fli1:EGFP)y1 embryos injected
with different doses of zve-ptp MOa (A); zve-ptp MOb (B) and zve-ptp
MOc (C). Injected embryos were scored for vascular, circulatory
and morphological defects at 2 dpf. The dose-response curves of
all MOs generate phenotypic classes of increasing severity in a
dose dependent manner. ‘‘Microhaemorrhages’’ refers to blood
stases in the head region, ‘‘Caudal blood stases’’ refers to blood cell
aggregates in the CV plexus, ‘‘absent circulation’’ refers to
embryos with no circulating elements and ‘‘reduced circulation’’
refers to a severely reduced blood flow in the trunk/tail region, ‘‘Se
defects’’ refers to intersomitic vessels characterized by anomalous
branching or truncated, ‘‘morphological defects’’ refers to
aberrant morphology of the tail and/or head.
(TIF)
Figure S2 The zve-ptp MOa injection caused angiogenic
defects at 2 dpf. (A–D) Confocal images of the tail of
tg(fli1:EGFP)y1 embryos injected with std-MO (A), zve-ptp MOa
(B), zve-ptp MOb (C) and zve-ptp MOc (D). Embryos injected with
MOa display intersomitic vessels which are either truncated or
characterized by anomalous branching (white arrowhead). Se:
intersomitic vessels; DLAVs: dorsal longitudinal anastomotic
vessels; DA: dorsal aorta; CV: caudal vein. (E–F) The efficiency
of splice-blocking is tested by RT-PCR with primers designed on
the exons flanking the MO target site. The injection of selected
doses of splice-blocking MOs (0.5 pmol/embryo of MOb and co-
injection of 0.2 pmol/embryo of MOc with 0.3 pmol/embryo of
p53 MO) resulted in the presence of the expected wild-type
fragment and the generation of an additional smaller band (red
box) corresponding to an aberrant transcript. The sizes of the
obtained PCR fragments are indicated. Diagrams in E and F show
the position of the zve-ptp MOb (MOb; designed on the intron 11/
exon 12 boundary), the position of the zve-ptp MOc (MOc;
designed on the intron 12/exon 13 boundary) and the position of
the specific primers (MObFOR2-MObREV2 and MOcFORB-
MOcREVB). Boxes represent exons (E11 to E14). The size of each
exon is indicated in the respective box.
(TIF)
Figure S3 zve-ptp MOc injection gave qualitatively
similar results to MOb injection, such as head haemor-
rhages and blood cell accumulations in the CV at 2 dpf.
Bright-field images of the head and the tail of std-MO (A, B) and
zve-ptp MOc injected embryos (C, D). MOc morphants showed
small haemorrhages (black arrowhead) in the head (C) and small
blood aggregates (red arrows) in CV (D). Anterior to the left. DA:
dorsal aorta; CV: caudal vein; black arrowhead: haemorrhage; red
arrow: blood aggregates.
(TIF)
Figure S4 The zve-ptpMOc injection caused an increase
in vascular permeability. (A–D) Microangiographies were
performed on tg(fli1:EGFP)y1 embryos at 2 dpf by the injection of
dextran-TMR (tetramethylrhodamine; molecular weight 70 kDa).
All microinjected embryos presented blood circulation. Confocal
images of tail vessels of std-MO (A, C) and MOc injected embryos
(B, D) at t1 = 10 minutes (A, B) and t2= 15 minutes (C, D). (E, F)
Merge of the images at t2 of embryos injected with std-MO and
MOc with the respective images of the tail vessels obtained using
tg(fli1:EGFP)y1 line. Asterisks: dye extravasation. (G) Histogram
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shows the percentage of embryos injected with MOa, MOb and
MOc that showed dye extravasation with respect to std-MO
injected embryos.
(TIF)
Figure S5 Statistical analysis of EC-EC borders in zve-
ptp MOa, MOb and MOc injected embryos. Quantitative
analysis of % EC-EC borders with any type of junctions (A),
without junctions but with digitiform EC-EC contacts (B) and
without junctions (C) in controls and in zve-ptp MOa, MOb and
MOc morphants. The analysis was performed on the TEM
acquired images of trunk and tail regions out of three std-MO and
five zve-ptp MOa, seven MOb and five MOc independent injected
embryos with a total of 112, 221, 150 and 280 EC-EC borders
analyzed respectively. *** p,0.001 vs std-MO; ** p,0.01 vs std-
MO.
(TIF)
Figure S6 siRNA knockdown of VE-PTP did not cause
alterations of both AJ and TJ architecture. Immunofluo-
rescence (A) and Western blot (B) analyses of the expression of the
major components of both AJs and TJs in HUVEC transfected
with non-Targeting or VE-PTP siRNAs. Scale bar: 20 mm.
(TIFF)
Movie S1 Circulation in a 2 dpf control embryo injected
with std-MO. Only caudal region is shown. Circulation can be
seen in the main axial vessels. Anterior to the left.
(AVI)
Movie S2 Circulation in a 2 dpf morphant injected with
zve-ptp MOb. Only caudal region is shown. Circulation can be
seen in the main axial vessels. Blood cell aggregates can be seen in
the caudal vein plexus. Anterior to the left.
(AVI)
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